相关参考文献
注意:仅列出部分参考文献,下载原文获取全部文献信息。MicroRNA-200c modulates DUSP-1 expression in diabetes-induced cardiac hypertrophy
Gurinder Bir Singh et al.
MOLECULAR AND CELLULAR BIOCHEMISTRY (2017)
Development of a liquid formulation of poorly water-soluble isosteviol sodium using the co-solvent technology
Wenshi Lai et al.
PHARMACEUTICAL DEVELOPMENT AND TECHNOLOGY (2017)
Lipid metabolism and its implications for type 1 diabetes-associated cardiomyopathy
Rebecca H. Ritchie et al.
JOURNAL OF MOLECULAR ENDOCRINOLOGY (2017)
Resveratrol Ameliorates Diabetes-Induced Cardiac Dysfunction Through AT1R-ERK/p38 MAPK Signaling Pathway
Yonglin Gao et al.
CARDIOVASCULAR TOXICOLOGY (2016)
Prohibitin overexpression improves myocardial function in diabetic cardiomyopathy
Wen-qian Dong et al.
ONCOTARGET (2016)
Liver X Receptor Agonist TO901317 Prevents Diacylglycerols Accumulation in the Heart of Streptozotocin-Diabetic Rats
Dorota Harasiuk et al.
CELLULAR PHYSIOLOGY AND BIOCHEMISTRY (2016)
Atorvastatin prevents advanced glycation end products (AGEs)-induced cardiac fibrosis via activating peroxisome proliferator-activated receptor gamma (PPAR-γ)
Miao Chen et al.
METABOLISM-CLINICAL AND EXPERIMENTAL (2016)
Neuroprotective Effects of Isosteviol Sodium Injection on Acute Focal Cerebral Ischemia in Rats
Hui Hu et al.
OXIDATIVE MEDICINE AND CELLULAR LONGEVITY (2016)
The Role of ERK1/2 in the Development of Diabetic Cardiomyopathy
Zheng Xu et al.
INTERNATIONAL JOURNAL OF MOLECULAR SCIENCES (2016)
GLP-1 analog liraglutide protects against cardiac steatosis, oxidative stress and apoptosis in streptozotocin-induced diabetic rats
Tomoaki Inoue et al.
ATHEROSCLEROSIS (2015)
The soluble guanylate cyclase activator cinaciguat prevents cardiac dysfunction in a rat model of type-1 diabetes mellitus
Csaba Matyas et al.
CARDIOVASCULAR DIABETOLOGY (2015)
Genistein ameliorates cardiac inflammation and oxidative stress in streptozotocin-induced diabetic cardiomyopathy in rats
Suresh K. Gupta et al.
MOLECULAR AND CELLULAR BIOCHEMISTRY (2015)
Cardiac-specific suppression of NF-κB signaling prevents diabetic cardiomyopathy via inhibition of the renin-angiotensin system
Candice M. Thomas et al.
AMERICAN JOURNAL OF PHYSIOLOGY-HEART AND CIRCULATORY PHYSIOLOGY (2014)
Advanced glycation end products: role in pathology of diabetic cardiomyopathy
Vijaya Lakshmi Bodiga et al.
HEART FAILURE REVIEWS (2014)
Diabetic cardiomyopathy: Mechanisms and new treatment strategies targeting antioxidant signaling pathways
Karina Huynh et al.
PHARMACOLOGY & THERAPEUTICS (2014)
Diabetic cardiomyopathy and its mechanisms: Role of oxidative stress and damage
Quan Liu et al.
JOURNAL OF DIABETES INVESTIGATION (2014)
Targeting the upregulation of reactive oxygen species subsequent to hyperglycemia prevents type 1 diabetic cardiomyopathy in mice
Karina Huynh et al.
FREE RADICAL BIOLOGY AND MEDICINE (2013)
Enhanced phosphoinositide 3-kinase(p110α) activity prevents diabetes-induced cardiomyopathy and superoxide generation in a mouse model of diabetes
R. H. Ritchie et al.
DIABETOLOGIA (2012)
Diabetic cardiomyopathy: understanding the molecular and cellular basis to progress in diagnosis and treatment
Ines Falcao-Pires et al.
HEART FAILURE REVIEWS (2012)
Amelioration of Renal Injury and Oxidative Stress by the nNOS Inhibitor L-VNIO in the Salt-sensitive mRen2. Lewis Congenic Rat
Liliya M. Yamaleyeva et al.
JOURNAL OF CARDIOVASCULAR PHARMACOLOGY (2012)
Stevioside and Related Compounds - Molecules of Pharmaceutical Promise: A Critical Overview
Goutam Brahmachari et al.
ARCHIV DER PHARMAZIE (2011)
RAGE biology, atherosclerosis and diabetes
Drazenka Pongrac Barlovic et al.
CLINICAL SCIENCE (2011)
Potential Role of Nuclear Factor kappa B in Diabetic Cardiomyopathy
O. Lorenzo et al.
MEDIATORS OF INFLAMMATION (2011)
Cannabidiol Attenuates Cardiac Dysfunction, Oxidative Stress, Fibrosis, and Inflammatory and Cell Death Signaling Pathways in Diabetic Cardiomyopathy
Mohanraj Rajesh et al.
JOURNAL OF THE AMERICAN COLLEGE OF CARDIOLOGY (2010)
Synthesis and In Vivo Acute Antihyperglycemic Evaluation of Novel Isosteviol Derivatives
Junqing Chen et al.
LETTERS IN DRUG DESIGN & DISCOVERY (2010)
Diabetic cardiomyopathy, causes and effects
Sihem Boudina et al.
REVIEWS IN ENDOCRINE & METABOLIC DISORDERS (2010)
Diabetic cardiomyopathy: signaling defects and therapeutic approaches
Joseph S. Dobrin et al.
EXPERT REVIEW OF CARDIOVASCULAR THERAPY (2010)
Endothelial Dysfunction in Diabetes: From Mechanisms to Therapeutic Targets
Maria Assunta Potenza et al.
CURRENT MEDICINAL CHEMISTRY (2009)
Rodent models of diabetic cardiomyopathy
Heiko Bugger et al.
DISEASE MODELS & MECHANISMS (2009)
Xanthine oxidase inhibitor allopurinol attenuates the development of diabetic cardiomyopathy
Mohanraj Rajesh et al.
JOURNAL OF CELLULAR AND MOLECULAR MEDICINE (2009)
被撤回的出版物: Advanced glycation endproduct (AGE) accumulation and AGE receptor (RAGE) up-regulation contribute to the onset of diabetic cardiomyopathy (Retracted article. See MAY, 2023)
Heng Ma et al.
JOURNAL OF CELLULAR AND MOLECULAR MEDICINE (2009)
Plasma glycooxidation protein products in type 2 diabetic patients with nephropathy
Agnieszka Piwowar et al.
DIABETES-METABOLISM RESEARCH AND REVIEWS (2008)
Measurement of cardiac function using pressure-volume conductance catheter technique in mice and rats
Pal Pacher et al.
NATURE PROTOCOLS (2008)
Inhibition of NADPH oxidase prevents advanced glycation end product-mediated damage in diabetic nephropathy through a protein kinase C-α-dependent pathway
Vicki Thallas-Bonke et al.
DIABETES (2008)
Isosteviol reduces plasma glucose levels in the intravenous glucose tolerance test in Zucker diabetic fatty rats
J. Ma et al.
DIABETES OBESITY & METABOLISM (2007)
The cardioprotective effect of isosteviol on rats with heart ischemia-reperfusion injury
Deyi Xu et al.
LIFE SCIENCES (2007)
The pathogenesis of myocardial fibrosis in the setting of diabetic cardiomyopathy
J Asbun et al.
JOURNAL OF THE AMERICAN COLLEGE OF CARDIOLOGY (2006)
Diabetes, oxidative stress, and antioxidants: A review
AC Maritim et al.
JOURNAL OF BIOCHEMICAL AND MOLECULAR TOXICOLOGY (2003)
Normalizing mitochondrial superoxide production blocks three pathways of hyperglycaemic damage
T Nishikawa et al.
NATURE (2000)